FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/044905 [Registered on: 25/08/2022] Trial Registered Prospectively
Last Modified On: 24/08/2022
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective 
Study Design  Single Arm Study 
Public Title of Study   Non-contact testing of vitals for the patients visiting Kasturba Hospital- Manipal 
Scientific Title of Study   Validation of non-contact based vitals screening technology in effective triaging of patients visiting Kasturba Hospital- Manipal  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Muralidhar Varma 
Designation  Additional Professor 
Affiliation  Kasturba Medical College And Hospital 
Address  Department of Infectious Diseases, Kasturba Medical College and Hospital. Madhav Nagar, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9845069639  
Fax    
Email  muralidhar.varma@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Muralidhar Varma 
Designation  Additional Professor 
Affiliation  Kasturba Medical College And Hospital 
Address  Department of Infectious Diseases, Kasturba Medical College and Hospital. Madhav Nagar, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9845069639  
Fax    
Email  muralidhar.varma@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Muralidhar Varma 
Designation  Additional Professor 
Affiliation  Kasturba Medical College And Hospital 
Address  Department of Infectious Diseases, Kasturba Medical College and Hospital. Madhav Nagar, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9845069639  
Fax    
Email  muralidhar.varma@manipal.edu  
 
Source of Monetary or Material Support  
Kasturba Medical College. Manipal Academy Of Higher Education. Manipal 
 
Primary Sponsor  
Name  Manipal Academy of Higher Education_Kasturba Medical College Manipal 
Address  Madhav Nagar, Manipal-576104 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Philips India Limited  Philips Innovation center Bangalore, Manyata Tech Park, Outer Ring Rd, Nagavara, Bengaluru, Karnataka 560045 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Muralidhar Varma  Kasturba Medical College. Manipal  Room No.15, Department of Infectious Diseases. Ground floor. Madhav Nagar. Manipal-576104
Udupi
KARNATAKA 
08202923875

muralidhar.varma@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital - Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: X||New Technology, (2) ICD-10 Condition: 4||Measurement and Monitoring,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1)All the clients (patients and patient caretakers) of Kasturba Hospital who are waiting for their entry into the hospital premises.
2)Both the genders of age group between 5 years to 80 years who can sit in the wheel chair and can walk independently and the care takers of the primary patient.
 
 
ExclusionCriteria 
Details  1)Unconscious, mentally challenged, non-comprehending patients and patients who are confined to stretchers.
2)Infants and children of age below 5 years
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1)The accuracy of the non-contact health screening technology will be significantly higher (60-75 percent) compared to a simple IR thermometer in identifying patients with a respiratory infection
2)The algorithm of non-contact health screening technology will be able to quantify the severity of sickness formulate an effective triaging protocol for pre-symptomatic, early symptomatic, moderate to severely infected Covid-19 other respiratory infection patients 
1)The recorded data will be analyzed, interpreted, findings will be reviewed every 15 days during the initial 6 months
2)Once the expert team is confident about the data accuracy, the findings were subjected to analysis at the end of every 8 weeks to test the primary outcomes.
 
 
Secondary Outcome  
Outcome  TimePoints 
Noncontact health screening technology will be able to reduce 50 to70 percent spread of infection from respiratory infected patients to others visiting hospitals

Noncontact screening technology will be able to reduce the screening time by 50 percent less compared to conventional screening procedure

Noncontact technology will help the better utilization of nurses, doctors for more deserving areas - inpatient care surgical theaters human intervention is irreplaceable. 
Efficacy of the kiosk for the intended function its secondary benefits will be analyzed & reviewed at the end of every one year.

The findings will be discussed with the experts the necessary modifications will be undertaken to improve the efficacy of the technology 
 
Target Sample Size   Total Sample Size="6800"
Sample Size from India="6800" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/08/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The purpose of this study is to validate the newly developed screening technology that can measure heart rate, respiratory rate and body temperature without any physical contact and can predict the status of patient’s health and wellness. The data obtained from this technology will be compared with the conventional method of recording  with physical contact to assess the accuracy of new technology. 

We the team of Kasturba hospital doctors and medical devices engineering experts have developed a new technology than can measure a person’s heart rate, respiratory rate and body temperature without touching their body. We believe that,  this technology will reduce the risk of  any cross infection among the fellow patients and doctors, nurses and other hospital staffs. This technology also will help the hospital team to effectively screen persons for COVID19 and other respiratory  infections and can identify the severity of underlying illness in persons who is sick and needs immediate treatment. This technology can also identify the persons with COVID19 infection even at very early stage and help them to get early treatment. Apart from screening for infections, this technology can also tell us about general body health and wellness to enable us to treat patient effectively. All the government guidelines are strictly followed for the safety of health care workers and the participants of the study. This technology will record video for one minute and will derive all vital parameters (heart rate , respiratory rate and body temperature) from the recorded video.

 

 
Close